RE: Three month results today.28 Sep 2022 11:35
From the results:
"We aim to continue capitalising on the benefits of our public listing,
expanding our existing product portfolio into new geographical
territories, increasing our direct-to-consumer sales of finished products,
and developing new technologies that offer enhanced potential for the
future. We will continue to work with AQUIS and explore opportunities
on other markets, including AIM, to increase liquidity in ProBiotix shares."